| Chemical | Toxicity Endpoint Type | Endpoint Description | Endpoint Value | Sample Size | Life Cycle Stage | Study Duration | Type |
|---|---|---|---|---|---|---|---|
| METHYLPARATHION | TOX-Non-Repro-Sublethal - behavioral effects | abnormal posture, ataxia, paresis | increased at 2, 3 mg/kg bw | 5/dose | Adult | 10 hr | Toxicity Factor Datasets |
| METHYLPARATHION | TOX-MORT - dose-response data | mortality rate 2 hr post-dose | increase at 3 mg/kg bw | 5/dose | Adult | 10 hr | Toxicity Factor Datasets |
| METHYLPARATHION | TOX-Non-Repro-Sublethal - whole animal | cloacal temperature | decrease at 2, 3 mg/kg bw | 5/dose | Adult | 10 hr | Toxicity Factor Datasets |
| METHYLPARATHION | TOX-EXP IND - biomarkers | plasma cholinesterase activity 2 hr post-dose | decrease at 2, 3 mg/kg bw | 5/dose | Adult | 10 hr | Toxicity Factor Datasets |
| METHYLPARATHION | TOX-Non-Repro-Sublethal - cellular/biochemical effects | brain acetylcholinesterase activity 10 hr post-dose | decrease at 1, 2, 3 mg/kg bw | 5/dose | Adult | 10 hr | Toxicity Factor Datasets |
| METHYLPARATHION | TOX-Non-Repro-Sublethal - cellular/biochemical effects | plasma glucose concentrations | increased at 2, 3 mg/kg bw | 5/dose | Adult | 10 hr | Toxicity Factor Datasets |
